glp-1 news employers Insurance Coverage Statistics 2026 | Employer, Medicare & Medicaid Data Employer Approaches to GLP-1 Coverage

The use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus does not increase the risk of pancreatic cancer: a U.S.-based cohort study

Understanding proper tirzepatide dosing for weight loss and semaglutide dosing is essential for minimizing these effects through proper escalation

6 Beyond their metabolic effects, recent studies suggest that GLP-1 RAs may have central nervous system activity and anti-inflammatory properties, making them a potential therapeutic option for conditions like IIH

The Outsourcing Facilities Association sued the FDA regarding the agencys sudden removal of tirzepatide, the key ingredient in Eli Lilly's Zepbound and Mounjaro